Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells.
about
Galectin-3 and Beclin1/Atg6 genes in human cancers: using cDNA tissue panel, qRT-PCR, and logistic regression model to identify cancer cell biomarkersMammalian target of rapamycin: a central node of complex signaling cascadesAutophagy in ageing and ageing-associated diseasesSirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular EffectsAutophagy and radiosensitization in cancerAutophagy modulation as a target for anticancer drug discoveryMYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitorsTherapeutic targeting of cancers with loss of PTEN function.The paradox role of caspase cascade in ionizing radiation therapyTargeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathwayM867, a novel selective inhibitor of caspase-3 enhances cell death and extends tumor growth delay in irradiated lung cancer modelsEGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cellsmTOR inhibition by everolimus in childhood acute lymphoblastic leukemia induces caspase-independent cell deathCombining mTOR inhibition with radiation improves antitumor activity in bladder cancer cells in vitro and in vivo: a novel strategy for treatment.EGFR-dependent and independent activation of Akt/mTOR cascade in bone and soft tissue tumors.RTOG 0913: a phase 1 study of daily everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy.GSK-3beta promotes cell survival by modulating Bif-1-dependent autophagy and cell deathAutophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy.Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor.Radiosensitization of prostate cancer by priming the wild-type p53-dependent cellular senescence pathway.p53 and ARF: unexpected players in autophagy.Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability.Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide.High expression of mTOR is associated with radiation resistance in cervical cancerEndoplasmic reticulum stress mediates radiation-induced autophagy by perk-eIF2alpha in caspase-3/7-deficient cells.Impaired Pten expression in human malignant peripheral nerve sheath tumours.Longitudinal imaging studies of tumor microenvironment in mice treated with the mTOR inhibitor rapamycin.Rapamycin enhances HBV production by inducing cellular autophagy.A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation.Small-molecule regulators of autophagy and their potential therapeutic applications.Rapamycin inhibits anal carcinogenesis in two preclinical animal models.Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycoside.Autophagy in lung cancerAutophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer.Autophagy in tumor suppression and cancer therapy.The mTOR inhibitor rapamycin suppresses DNA double-strand break repairAutophagy: friend or foe in breast cancer development, progression, and treatmentA switch between cytoprotective and cytotoxic autophagy in the radiosensitization of breast tumor cells by chloroquine and vitamin D.Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy
P2860
Q21134996-064D1279-DA72-4600-9431-35D9206CBB63Q24601702-4A30338D-8DD2-48E1-BF8C-5E484D030496Q24629560-CADB0C0B-3811-4AE4-AACE-0291D82F86BEQ26749011-50CC3420-E0D8-456E-94FB-0CE2BDA689DCQ26865330-E1563009-278D-49B2-B9FA-3F5748B1144EQ27025391-10EFDDC2-ABD2-4650-BAAB-151A4F94FA2CQ27350187-D4C031A2-E2E9-4481-A00A-EF712F07E293Q27852764-510FDE8F-936A-41AD-A6F0-D2A9A3F4D205Q28079723-ED12AACF-3E75-4747-A11F-C2C38C6C7FA4Q28382812-B3EB0DCE-432A-4709-A652-244FABBC955CQ28472801-9916F563-BA73-419B-BBF1-02C2EDAFDC39Q28478401-1AD3E5E3-30B7-4E17-8C0B-658ABE0CB64DQ28540672-95885467-3527-4869-8BBC-4D981F826CECQ31120012-C238115A-3192-4584-B604-D9D6E7C526DEQ33273472-A041BCD3-9A98-4583-BDB6-148C5B1311C4Q33408116-B4648C70-85D3-477E-BDFC-6D07F1ADA4CCQ33653171-D39C49AB-E033-4593-AAAC-0B9418E322EFQ33701939-A9559735-C78E-48A9-8439-9F9913CAFAEAQ33839054-4A0EF0B8-4107-4EA3-96C7-482F6AE8EFF7Q33926261-2731C780-F403-4D84-A4A5-ECE94A47110EQ33926909-F62E3E0E-A800-456E-AB7A-6C782D5C108CQ33936026-85C8236E-B8F3-4942-BF67-47989AAD1E12Q34096767-436FC3F2-E622-4570-942B-14B16A65569FQ34144553-F02F43A3-249F-4FEB-94C7-737A79733318Q34167071-DF5F7859-5776-47F5-B10E-E42C72312FB7Q34193898-EE7C8B4D-4F5E-4BF4-AF7A-A537E2DA389CQ34471826-43292CB7-1D19-4A2A-A18E-0436F7C67858Q34490050-2E90EF57-386F-492A-A274-E6AE30C8FA40Q34546155-4EDA58C1-268D-431E-A756-FBA9290779D6Q34572724-088A263E-B759-4A82-B628-4739E02C280AQ34660074-52E1EBAA-5547-4B5E-84A2-3485B18608A1Q34679829-4C7E8670-526F-46F6-8D10-396BC5D09CE5Q34720018-31F8DA17-DB87-4867-889F-824B5B538EE8Q34764083-635D96DE-D6BF-4568-8971-385CCBFEA76DQ34775716-28FBCA1D-8924-439A-AD2D-4B7AC0AA22AEQ35276016-1C7133B6-4B99-4124-BD01-2A88F63D9708Q35545852-A452B8E3-76FA-4EA6-AFB2-F7A72D17CF19Q35684456-D0990803-D64A-4CE0-9389-7C57260F81C2Q35750508-CC4AD840-5904-450C-ACF1-F474A07F776DQ35972736-F77B61FC-716F-405A-BAE7-4F1431974BAB
P2860
Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Inhibition of mammalian target ...... EN null prostate cancer cells.
@en
type
label
Inhibition of mammalian target ...... EN null prostate cancer cells.
@en
prefLabel
Inhibition of mammalian target ...... EN null prostate cancer cells.
@en
P2093
P1433
P1476
Inhibition of mammalian target ...... EN null prostate cancer cells.
@en
P2093
Carolyn Cao
Jeffrey M Albert
Konjeti R Sekhar
Kwang Woon Kim
Ty Subhawong
Young Jin Gi
P304
10040-10047
P356
10.1158/0008-5472.CAN-06-0802
P407
P577
2006-10-01T00:00:00Z